论文部分内容阅读
我院自1997年4月～1998年7月采用沈阳博斯林公司生产的QDZ-Ⅱ型前列腺电解治疗仪经尿道电解治疗前列腺增生症(BPH)患者27例,疗效满意。 1 临床资料 本组27例,年龄55～87岁,平均年龄69岁,均具有典型的BPH临床表现。前列腺指诊:Ⅰ°7例,Ⅱ°12例,Ⅲ°8例;国际前列腺症状评分(Ⅰ—PSS) 12～35分,平均23.4分:生活质量评分(QOL)3～6分,平均4.6分。本组27例中有11例为急性尿潴留,其余16例术前最大尿流率(MFR)5～12ml/s,平均尿流率(PFR)8.2ml/s,剩余尿(RU)40～230ml,平
Our hospital from April 1997 to July 1998 by Shenyang Bosilin company QDZ-Ⅱ prostate electrolysis treatment of transurethral electrolysis in patients with benign prostatic hyperplasia (BPH) in 27 patients, the effect is satisfactory. 1 Clinical data The group of 27 patients, aged 55 to 87 years, mean age 69 years, with typical clinical manifestations of BPH. Prostate referral: Ⅰ ° 7 cases, Ⅱ ° 12 cases, Ⅲ ° 8 cases; International Prostate Symptom Score (I-PSS) 12 to 35 points, mean 23.4 points: Quality of life score (QOL) 3 to 6 points, an average of 4.6 Minute. In the group of 27 cases, 11 cases had acute urinary retention, the remaining 16 cases had preoperative maximum flow rate (MFR) of 5-12ml / s, mean flow rate (PFR) of 8.2ml / s, residual urine (RU) 230ml, flat